Single-dose of adrecizumab versus placebo in acute cardiogenic shock (ACCOST-HH): an investigator-initiated, randomised, double-blinded, placebo-controlled, multicentre trial-Reference-Cited by-同舟云学术

Single-dose of adrecizumab versus placebo in acute cardiogenic shock (ACCOST-HH): an investigator-initiated, randomised, double-blinded, placebo-controlled, multicentre trial

Published:2021-12 Issue: Volume: Page:
ISSN:2213-2600
Container-title:The Lancet Respiratory Medicine
language:en
Short-container-title:The Lancet Respiratory Medicine

Author:

Karakas Mahir,Akin Ibrahim,Burdelski Christoph,Clemmensen Peter,Grahn Hanno,Jarczak Dominik,Keßler Mirjam,Kirchhof Paulus,Landmesser Ulf,Lezius Susanne,Lindner Diana,Mebazaa Alexandre,Nierhaus Axel,Ocak Anil,Rottbauer Wolfgang,Sinning Christoph,Skurk Carsten,Söffker Gerold,Westermann Dirk,Zapf Antonia,Zengin Elvin,Zeller Tanja,Kluge Stefan

Funder

Universitatsklinikum Hamburg-Eppendorf

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference26 articles.

1. Cardiogenic shock;Vahdatpour;J Am Heart Assoc,2019

2. Management of cardiogenic shock;Thiele;Eur Heart J,2015

3. PCI strategies in patients with acute myocardial infarction and cardiogenic shock;Thiele;N Engl J Med,2017

4. Management of refractory cardiogenic shock;Reyentovich;Nat Rev Cardiol,2016

5. Acute Cardiovascular Care Association position statement for the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock: A document of the Acute Cardiovascular Care Association of the European Society of Cardiology

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Inflammation in the Pathogenesis of Cardiogenic Shock Secondary to Acute Myocardial Infarction: A Narrative Review;Biomedicines;2024-09-11

2. Biomarker patterns in patients with cardiogenic shock versus septic shock;IJC Heart & Vasculature;2024-06

3. Cardiogenic Shock: Insights from Recent Randomized Clinical Trials;American Journal of Respiratory and Critical Care Medicine;2024-05-15

4. High Circulating Dipeptidyl Peptidase 3 Predicts Mortality and Need for Organ Support in Cardiogenic Shock: An Ancillary Analysis of the ACCOST-HH Trial;Journal of Cardiac Failure;2024-04

5. Bioactive adrenomedullin (bio-ADM) is associated with endothelial dysfunction in infants and children with complex congenital heart disease undergoing open-heart surgery on cardiopulmonary bypass;Clinical Chemistry and Laboratory Medicine (CCLM);2023-10-24